Neuro Event Labs, Nelli® officially received European MDR (Medical Device Regulation) certification as a Class…
Continue Reading-
TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001
TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001 — Hadean Ventures…
Continue Reading -
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type…
Continue Reading -
SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating theCompany’s Lead Development Program SR-878
SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating theCompany’s Lead Development Program SR-878 — Hadean…
Continue Reading -
Alex Therapeutics has signed an exclusive agreement with Navamedic
Alex Therapeutics has signed an exclusive agreement with Navamedic — Hadean Ventures Home Portfolio Team…
Continue Reading -
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease — Hadean Ventures…
Continue Reading -
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa
ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa...
Continue Reading -
Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial
Alex Therapeutics Reports Positive Results...
Continue Reading